Troy Wilson, Kura Oncology CEO
Kura Oncology secures up to $150M in Bristol Myers equity investment, loan from Hercules Capital
Kura Oncology is set for a few more years, thanks to some new partners.
The public oncology biotech put out word last week that it …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
